Garofalo Health Care Finalizes Acquisition of Casa di Cura Città di Roma

Reuters01-19
Garofalo Health Care Finalizes Acquisition of Casa di Cura Città di Roma

Garofalo Health Care S.p.A. has finalized the acquisition of Casa di Cura Città di Roma, a multi-specialist acute care facility accredited with the National Healthcare Service. As part of the transaction, a new governance structure for Città di Roma has been established, with Mariano Garofalo appointed as Chairman, Maria Laura Garofalo and Claudia Garofalo as Directors, and Piergiuseppe Bagnera as Single Auditor. Raffaella Ferradini has been introduced as the new General Manager, bringing 13 years of experience in healthcare management. The acquisition marks the launch of a transformative reorganization plan for Casa di Cura Città di Roma, Aurelia Hospital, and European Hospital, with the aim of realigning healthcare services to better meet local needs. Following the reorganization, Casa di Cura Città di Roma will become a post-acute care facility equipped with an outpatient diagnostic department and two state-of-the-art dialysis rooms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Garofalo Health Care S.p.A. published the original content used to generate this news brief on January 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment